Ads
related to: post inflammatory erythema not fading due to chemo medication chart printable- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Find A Doctor
Search results
Results From The WOW.Com Content Network
The main treatment for acral erythema is discontinuation of the offending drug, and symptomatic treatment to provide analgesia, lessen edema, and prevent superinfection. However, the treatment for the underlying cancer of the patient must not be neglected. Often, the discontinued drug can be substituted with another cancer drug or cancer treatment.
Treatment for postinflammatory hyperpigmentation may include topical agents like hydroquinone, retinoids, ascorbic acid, and azelaic acid, as well as chemical peels or laser therapy to promote skin renewal and reduce pigmentation. Sun protection is also crucial to prevent further darkening of the affected skin.
Hypopigmented lesions can range in color from hypopigmentation to depigmentation, and their size, form, and primary inflammatory dermatosis frequently correspond with each other. Complete depigmentation is more noticeable in people with darker skin and is frequently observed in cases of discoid lupus erythematosus and severe atopic dermatitis .
Erythema (Ancient Greek: ἐρύθημα, from Greek erythros 'red') is redness of the skin or mucous membranes, caused by hyperemia (increased blood flow) in superficial capillaries. [1] It occurs with any skin injury, infection, or inflammation .
Some reactions, such as pain, may appear immediately. Others may be delayed, such as erythema which may appear 24–96 hours after injection. [2] ISRs commonly seen with subcutaneous injections include: Bleeding and bruising [3] Erythema (redness) Pain; Pruritis (itching) [4] Swelling [5] Induration (hardening of the skin) [6] Discoloration [6]
The culprit can be both a prescription drug or an over-the-counter medication. Examples of common drugs causing drug eruptions are antibiotics and other antimicrobial drugs, sulfa drugs, nonsteroidal anti-inflammatory drugs (NSAIDs), biopharmaceuticals, chemotherapy agents, anticonvulsants and psychotropic drugs.